UnitedHealth Group stock plummets on DOJ investigation report

United State Group (:Light) had another rude day of trading on Friday.

According to DOJ, the Department of Justice (DOJ) investigates its Medicare’s advantage insurance businesses to send more than 8% lower in early commerce.

Civil fraud investigation, first reported by Wall Street JournalStudy how the United States records are studied, which promote payments from Medicare and Medicaid Services (CMS). CMS pays lump sums of private insurers to ensure an alternative Coverage of Medicare.

The United Healthcare has called for misinformation in the report on Friday.

“The Wall Street Journal Continues to notify misinformation about Medicare’s advantage (MA) program. The government regularly reviews all MA programs to ensure compliance, and we consistently perform at the highest levels of industry, “the statement said.

The United Health added that the company was not aware of the new activities by DOJ.

Friday news reports this year sixth time, the shares were sold this week and the second time. At the beginning of this week, the company is reported offered buyers to employees About his health insurance business, the United Kingdom, which is considered out of work if it did not reach the purchase goal.

It’s just the last headscarf that the company cares over the past 12 months. The United Target was the target of common cyber security last year has affected over 190 million – A number of company revealed only at the beginning of this year.

Doj also studied the company For possible breakthrough and Federal Trade Commission (FTC) could block his last achievementA number

In addition, the company suffered a tragedy in December with its highest insurance executive, Brian Thompson’s shots and death. The attack stunning waves sent through industry in public feedback.

The company’s $ 460 billion has fallen under all these pressure, noting significantly the prospects of its growth in the primary age when the healthcare company became the first trillion.

Analyze Kachm The senior health journalist is in Yahoo Finance, including all the things Pharma, Insurance, Care Services, Digital Health, PRBM and Health Policy and Politics. It includes GLP-1S, of course. Follow Anjalee Social Media Platform X, LinkedIn and Bluesky @Anjkhem:A number

Click here to the latest news and events of the latest health industry that affect stock prices